Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   
Biosimilar Medicines: Core Principles and Communication

Biosimilar Medicines: Core Principles and Communication

en English

Proceed to module  Shortlist  Rate Module  Share
Language

en English

Summary Designed to promote a clear understanding of biosimilar medicines with a focus on improving patient education through good communication.
Description

This project was made possible through a collaboration between European Cancer Patient Coalition (ECPC), King’s College London and ecancer. Developed to support the clinical practice of physicians prescribing biosimilar medicines to cancer patients. The content is designed to promote a clear understanding of biosimilar medicines with a focus on improving patient education through good communication.

This module was published July 2019.

Target Audience

This module is developed for clinicians prescribing biosimilars to patients. 

Learning Objectives

By the end of the module you will:

  • Be able to define a biosimilar product vs generic product.
  • Understand how the ‘nocebo effect’ occurs and how to prevent it.
  • Understand the ethics around interchangeability and switching biosimilar medicines.
  • Acquire key patient communication skills to help you answer difficult questions on biosimilars.
Accreditation

This module awards the learner 1 CME point upon successful completion and passing of the assessment.

IT Requirements

This module requires the learner to have a good, stable internet connection and runs best on HTML supported web browsers, however, can also run on FLASH enabled web browsers.

If you are viewing this module on an iPad (through a browser), please download the free Articulate Mobile Player beforehand. Other tablet devices may not be compatible - please check for Flash compatibility.

If you are experiencing technical difficulties, please contact education@ecancer.org and we will get back to you as soon as possible.

Commercial Support

Production of this module was funded by an unrestricted grant from Pfizer. 

Disclosure Policy

ecancer and everyone involved in the development of this module has no actual or potential conflict of interest whatsoever which impinges on the making, peer reviewing and dissemination of this e-learning module which was made possible through an unrestricted educational grant from Pfizer.

Pfizer has had no input in the creation of the e-learning materials including the process of selecting speakers.

For more information, please email education@ecancer.org

Proceed to Module

Relevant to the following professions

  • Nurse
  • Oncologist
  • Other
  • Public Health
Proceed to module  Shortlist  Rate Module


Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation